Related Experiment Video
Updated: May 16, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
[A 10-day sequential therapy for eradication of Helicobacter pylori infection in children]
Jing Huang1, Si-tang Gong, Wen-ji Ou
1Department of Gastroenterology, Guangzhou Women and Children's Medical Center, Guangzhou, China.
Insights
The 10-day sequential therapy effectively eradicates Helicobacter pylori (Hp) infection in children, showing higher success rates than 7-day and 10-day triple therapies. This regimen offers a promising alternative for pediatric Hp treatment.
Area of Science:
- Pediatric Gastroenterology
- Infectious Diseases
- Microbiology
Background:
- Helicobacter pylori (Hp) infection is a common cause of abdominal pain in children.
- Effective eradication therapies are crucial to prevent long-term complications.
- Optimizing treatment regimens for pediatric populations is an ongoing clinical challenge.
Purpose of the Study:
- To evaluate the clinical efficacy of a 10-day sequential therapy for eradicating Hp infection in children.
- To compare the Hp eradication rates of a 10-day sequential regimen with various triple therapy durations (7, 10, and 14 days).
Main Methods:
- A randomized controlled trial involving 214 children with confirmed Hp infection.
- Four treatment groups: 10-day sequential therapy, 7-day triple therapy, 10-day triple therapy, and 14-day triple therapy.
- Efficacy assessed using the (13)C urea breath test four weeks post-treatment.
Main Results:
- The 10-day sequential therapy achieved significantly higher Hp eradication rates (85.2% ITT, 90.2% PP) compared to 7-day (66.0% ITT, 71.4% PP) and 10-day triple therapies (60.0% ITT, 67.3% PP).
- No significant difference in eradication rates was observed between the 10-day sequential therapy and the 14-day triple therapy.
- All groups showed comparable rates of abdominal pain relief and adverse reactions.
Conclusions:
- The 10-day sequential regimen is a highly effective treatment for eradicating Hp infection in children.
- This regimen demonstrates superior efficacy over shorter triple therapy durations.
- While effective, the 10-day triple regimen offers advantages in treatment duration and patient compliance.
Objective:
To evaluate the clinical effect of a 10-day sequential therapy which was made up of omeprazole, clarithromycin, amoxicillin-clavulanate and metronidazole for the eradication of Helicobacter pylori (Hp) infection in children.
Method:
A total of 214 children with abdominal pain, who were confirmed to have Hp infection through endoscopy, biopsy, and Hp culture. The 214 cases were randomly divided into four groups. A 10-day sequential therapy group accepted omeprazole 0.8 - 1.0 mg/(kg·d) plus amoxicillin-clavulanate 50 mg/(kg·d) for five days and omeprazole 0.8 - 1.0 mg/(kg·d), clarithromycin 20 mg/(kg·d) and metronidazole 20 mg/(kg·d) for the remaining five days. The 7-day triple therapy group, 10-day triple therapy group and 14-day triple therapy group received omeprazole 0.8 - 1.0 mg/(kg·d), amoxicillin-clavulanate 50 mg/(kg·d) and clarithromycin 20 mg/(kg·d) for 7 days,10 days,14 days, respectively. All drugs were given twice daily. All these patients received (13)C urea breath test ((13)C-UBT) four weeks after the treatment.
Result:
Finally, 199 patients were followed up, and the total rate of loss to follow-up was 7.0% (15/214). Hp eradication rate was 85.2% and 90.2% in the 10-day sequential therapy group on intention to treat (ITT) and per protocol (PP) analyses, 66.0% and 71.4% in the 7-day triple therapy group on ITT and PP analyses; 60.0% and 67.3% in 10-day triple therapy group on ITT and PP analyses, and 78.8% and 82.0% in patients who received the 10-day sequential regimen on ITT and PP analyses, respectively. By ITT analysis, there was significantly difference between the 10-day sequential therapy group and 7-day or 10-day triple therapy group (P < 0.05), while no significant difference was found between the 10-day sequential therapy group and 14-day triple therapy group (P > 0.05). The results of the ITT analysis and the PP analysis were the same. The four groups had neither significant difference in abdominal pain relief (P > 0.05) nor in incidence of adverse reactions (P > 0.05).
Conclusion:
The 10-day sequential regimen was significantly more effective than both 7-day triple regimen and 10-day triple regimen, while had the same eradication rate compared with the 14-day sequential therapy. But 10-day triple regimen to eradicate Hp infection in children had the advantages such as short course of treatment and better compliance.
More Related Videos
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.